EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-SA 4.0

Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study

Karla Seamon, Frank Sanfilippo, Max Bulsara, Libby Roughead, Anna Kemp-Casey, Caroline Bulsara, Gerald F Watts, David Preen

Public Health Research and Practice · 10.03.2020 · 30 (1)

DOI: 10.17061/phrp29121905 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Public Health Research and Practice, online erschienen am 10.03.2020. Verfasst von Karla Seamon und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, University of Notre Dame, Perth, WA, Australia; School of Nursing and Midwifery, Edith Cowan University, Perth, WA, Austra…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Previous Australian research has shown that following the 21% increase in patient copayments for medications on the Pharmaceutical Benefits Scheme (PBS) in 2005, the use of lipid-lowering therapy declined by 5%. This study aimed to determine the demographic and clinical characteristics of individuals who continued, reduced or ceased their use of statin medication in 2005. Study type: Retrospective observational study using routinely collected administrative data.

Method

We used pharmaceutical claims, hospital separations and mortality records from 2000 to 2005 for the Western Australian population. The cohort comprised stable users of statin medication in 2004. Based on changes in statin use between 2004 and 2005, we identified individuals who: 1) continued using statins; 2) reduced their use by ≥20%; or 3) ceased therapy for at least the first 6 months in 2005. Multivariate logistic regression models were used to determine whether the demographic and clinical characteristics of the three groups differed.

Results

There were 205 924 statin users identified in Western Australia as of December 2004. After the January 2005 Pharmaceutical Benefits Scheme (PBS) copayment increase, 3.2% of users ceased their regular statin therapy, 12.9% reduced statin use and 83.9% continued statin use. This represented a 2.1% increase in statin users reducing or ceasing therapy compared to 2004. Predictors of cessation and reduction of statin therapy included younger age, greater socio-economic disadvantage, residing in very remote areas, having general beneficiary status, being a new statin user, having no prior history of ischaemic heart disease, having no prior history of a coronary artery revascularisation procedure, taking no other cardiovascular medication or diabetic medication, taking an increased number of medications, and having a lower level of adherence to statin medication in 2004.

Conclusion

Compared to 2004, an additional 2.1% of statin users reduced or discontinued medication use in 2005, which may be attributed to an increase in the medication copayment. Individuals with general beneficiary status, and younger and healthier people were at particular risk of cessation or reduction in statin use in 2005.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAged, 80 and overCohort StudiesDuration of TherapyHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHyperlipidemiasMaleMiddle AgedRetrospective StudiesWestern Australia

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • School of Health Sciences, University of Notre Dame, Perth, WA, Australia; School of Nursing and Midwifery, Edith Cowan University, Perth, WA, Australia; karla.seaman1@my.nd.edu.au.
  • Cardiovascular Research Group, School of Population and Global Health, University of Western Australia, Perth.
  • Institute for Health Research, University of Notre Dame, Perth, WA, Australia.
  • Sansom Institute for Health Research, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide.
  • Centre for Health Services Research, School of Population and Global Health, University of Western Australia, Perth.
  • School of Health Sciences, University of Notre Dame, Perth, WA, Australia.

Zitieren

APA

Seamon, K., Sanfilippo, F., Bulsara, M., Roughead, L., Kemp-Casey, A., Bulsara, C., Watts, G. F., & Preen, D. (2020). Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study. Public Health Research and Practice, 30(1). https://doi.org/10.17061/phrp29121905

Vancouver

Seamon K, Sanfilippo F, Bulsara M, Roughead L, Kemp-Casey A, Bulsara C, et al. Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study. Public Health Research and Practice. 2020;30(1). doi:10.17061/phrp29121905

BibTeX
@article{Seamon2020,
  author = {Seamon, Karla and Sanfilippo, Frank and Bulsara, Max and Roughead, Libby and Kemp-Casey, Anna and Bulsara, Caroline and Watts, Gerald F and Preen, David},
  title = {Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study},
  journal = {Public Health Research and Practice},
  year = {2020},
  volume = {30},
  number = {1},
  doi = {10.17061/phrp29121905}
}
Kostenlos starten →